LIBRIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Librium, and when can generic versions of Librium launch?
Librium is a drug marketed by Bausch and Valeant Pharm Intl and is included in five NDAs.
The generic ingredient in LIBRIUM is chlordiazepoxide hydrochloride. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Librium
A generic version of LIBRIUM was approved as chlordiazepoxide hydrochloride by CHARTWELL RX on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIBRIUM?
- What are the global sales for LIBRIUM?
- What is Average Wholesale Price for LIBRIUM?
Summary for LIBRIUM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,386 |
| DailyMed Link: | LIBRIUM at DailyMed |
Recent Clinical Trials for LIBRIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Bristol | Phase 4 |
| VA Salt Lake City Health Care System | Phase 4 |
Pharmacology for LIBRIUM
| Drug Class | Benzodiazepine |
US Patents and Regulatory Information for LIBRIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085475-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bausch | LIBRIUM | chlordiazepoxide hydrochloride | INJECTABLE;INJECTION | 012301-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Valeant Pharm Intl | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085472-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Valeant Pharm Intl | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085461-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIBRIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 012249-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Bausch | LIBRIUM | chlordiazepoxide hydrochloride | INJECTABLE;INJECTION | 012301-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Valeant Pharm Intl | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 012249-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Valeant Pharm Intl | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 012249-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
